Metformin 2gm/day in NSCLC patients had a significantly lower survival than chemoradiotherapy alone
Finding the best treatment for cancer. Complementary and alternative cancer therapies that are scientifically proven.
Metformin 2gm/day in NSCLC patients had a significantly lower survival than chemoradiotherapy alone
Leave a comment